bioMérieux Ge...
18th March 2025 Content supplied by: bioMérieux (Clinical Diagnostics)
bioMérieux Receives FDA 510(k) Clearance for its VITEK® COMPACT PRO
bioMérieux has announced FDA 510(k) clearance for VITEK® COMPACT PRO, enhancing microorganism identification (ID) and antibiotic susceptibility testing (AST).
This system aims to combat antimicrobial resistance (AMR) and improve diagnostic accuracy in clinical and industrial laboratories.
Annually, 11 million deaths occur from sepsis, with 1.3 million linked to antibiotic-resistant bacteria, underscoring the need for efficient diagnostics.
VITEK® COMPACT PRO offers:
- Ergonomic design and simplified workflow for improved user experience.
- Fastest routine ID/AST results, enhancing laboratory efficiency.
- Ideal for small and medium-sized labs transitioning from manual to automated processes.
The product will ensure the quality and safety of food, pharmaceutical, and cosmetic products in industrial settings.
The commercial launch is set for select countries, with a global rollout planned for the second quarter of 2025.
Tags:
Date Published: 18th March 2025
Source article link: View
bioMérieux Gets FDA
bioMérieux (Clinical Diagnostics)
Address:
Marcy L'Etoile
France
Related news from bioMérieux (Clinical Diagnostics)
- bioMérieux Gets FDA Approval for BIOFIRE® FILMARRAY® Gastrointestinal Panel Mid
- BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel Receives FDA Clearance
- BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel Mini Receives FDA Special Clearance and CLIA Waiver
- bioMérieux's AST System VITEK® REVEAL Achieves FDA 510(k) Clearance
- FDA Clearance and CLIA-waiver for bioMerieux's BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
- US FDA CLIA-waiver for BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini
- BioFire Defense Partners With BARDA
- FDA Clearance and CLIA-waiver for Fast and Innovative BIOFIRE® SPOTFIRE® POC System
- MAESTRIA™, a New Generation Microbiology Middleware Optimizes Laboratory Workflow
- VIDAS® KUBE™ - the Next-generation VIDAS® System Receives CE Marking
- FDA Breakthrough Device Designation for SPECIFIC REVEAL® Rapid AST System
- Added Medical Value with Urine Sample Results Up to 8 Hours Faster
- bioMérieux to Distribute Specific Diagnostics’ REVEAL Rapid AST System in Europe
- Enhanced BIOFIRE® Blood Culture Identification 2 (BCID2) Panel Submitted for FDA Clearance
- Spotlight on Antimicrobial Stewardship with bioMérieux
- New FDA Clearance for VITEK® MS: Expanded ID for Challenging Pathogens
- PhenoMATRIX™ for WASPLab®: AI for Sample Interpretation & Sorting
- BIOFIRE® FILMARRAY® Pneumonia Panels Gain FDA clearance and CE Marking
- bioMérieux and DIAGNOSTICS IS POWER at ECCMID 2018
- FDA Clears Identification of Mycobacteria, Nocardia and Moulds on VITEK® MS